ASTAXANTHIN ESTERS FOR THE INHIBITION AND AMELIORATION OF DISEASE

A chemical compound having the structure where each Y is independently O or H 2 ; where each R is independently -alkyl-NR 2 3 , -alkyl-CO 2 - , or -amino acid-NH 3 + ; where each R 2 is independently H, alkyl, or aryl, as well as its use in treating cardiovascular disease, a disease which produces r...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LOCKWOOD, SAMUEL, FOURNIER, HIX, LAURA, M, JACKSON, HENRY, NADOLSKI, GEOFF, O'MALLEY, SEAN, WATUMULL, DAVID, G
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM AGRICULTURE ANIMAL HUSBANDRY BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES CHEMISTRY DERIVATIVES THEREOF FISHING FORESTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HUNTING HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEST REPELLANTS OR ATTRACTANTS PLANT GROWTH REGULATORS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS TRAPPING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A chemical compound having the structure where each Y is independently O or H 2 ; where each R is independently -alkyl-NR 2 3 , -alkyl-CO 2 - , or -amino acid-NH 3 + ; where each R 2 is independently H, alkyl, or aryl, as well as its use in treating cardiovascular disease, a disease which produces reactive oxygen species, liver disease, disease which comprises cancerous and pre-cancerous cell(s), disease comprising increasing cannexin 43 expression or reducing C-reactive protein, gastrointestinal disease, muscoskeletal disease.